| centanafadine SR (EB-1020) / Otsuka |
NCT03605680: A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder |
|
|
| Completed | 3 | 604 | US | Centanafadine SR, EB-1020, Placebo | Otsuka Pharmaceutical Development & Commercialization, Inc. | Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder | 04/20 | 04/20 | | |
NCT03605836: A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder |
|
|
| Completed | 3 | 590 | US | Centanafadine SR, EB-1020, Placebo | Otsuka Pharmaceutical Development & Commercialization, Inc. | Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder | 05/20 | 05/20 | | |
NCT03605849: A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder |
|
|
| Completed | 3 | 660 | US | Centanafadine SR, EB-1020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder | 09/21 | 09/21 | | |
NCT05257265: A Trial of Centanafadine Efficacy and Safety in Adolescents With Attention- Deficit/Hyperactivity Disorder |
|
|
| Completed | 3 | 459 | US | Centanafadine Hydrochloride, Centanafadine QD XR, Placebo, Matching Placebo | Otsuka Pharmaceutical Development & Commercialization, Inc. | Attention-Deficit/Hyperactivity Disorder | 09/23 | 10/23 | | |
NCT05428033: A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD) |
|
|
| Recruiting | 3 | 570 | US | centanafadine capsule, centanafadine, centanafadine XR, EB-1020, placebo capsule, placebo comparator, matching placebo | Otsuka Pharmaceutical Development & Commercialization, Inc. | Attention Deficit/Hyperactivity Disorder | 10/25 | 10/25 | | |
NCT05279313: A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) |
|
|
| Recruiting | 3 | 700 | US | Centanafadine Hydrochloride, Centanafadine, Centanafadine XR, EB-1020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | Attention Deficit/Hyperactivity Disorder | 11/24 | 11/24 | | |
